相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules
Siow-Feng Chong et al.
BIOMATERIALS (2009)
The path to a successful vaccine adjuvant - 'The long and winding road'
Derek T. O'Hagan et al.
DRUG DISCOVERY TODAY (2009)
Pattern recognition receptors and control of adaptive immunity
Noah W. Palm et al.
IMMUNOLOGICAL REVIEWS (2009)
Poly(I:C) coated PLGA microparticles induce dendritic cell maturation
Christian Wischke et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
MyD88 Adaptor-Like Is Not Essential for TLR2 Signaling and Inhibits Signaling by TLR3
Elaine F. Kenny et al.
JOURNAL OF IMMUNOLOGY (2009)
Emerging role of Toll-like receptors in atherosclerosis
Linda K. Curtiss et al.
JOURNAL OF LIPID RESEARCH (2009)
A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge
X. Zhang et al.
MUCOSAL IMMUNOLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation
Roger Belizaire et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting atherosclerosis by using modular, multifunctional micelles
David Peters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity
J. J. C. de Vries et al.
VACCINE (2009)
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Ruth D. Ellis et al.
VACCINE (2009)
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+T-cells, memory CD8+T-cells, and pro-inflammatory cytokines
Nicholas J. Steers et al.
VACCINE (2009)
Eleven years of Inflexal® V-a virosomal adjuvanted influenza vaccine
Christian Herzog et al.
VACCINE (2009)
Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
Satoshi Ohno et al.
VACCINE (2009)
A cell biological view of Toll-like receptor function: regulation through compartmentalization
Gregory M. Barton et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research
Hong Huang Lin et al.
BMC BIOINFORMATICS (2008)
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Hong Huang Lin et al.
BMC IMMUNOLOGY (2008)
Central role of dendritic cells in the regulation and deregulation of immune responses
F. Granucci et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
C. R. Casella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Self-adjuvanting lipopeptide vaccines
Peter M. Moyle et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Virus-sized vaccine delivery systems
Jean-Pierre Y. Scheerlinck et al.
DRUG DISCOVERY TODAY (2008)
When signaling pathways collide: Positive and negative regulation of Toll-like receptor signal transduction
Luke A. J. O'Neill
IMMUNITY (2008)
Vaccine adjuvants alter TCR-based selection thresholds
Laurent Malherbe et al.
IMMUNITY (2008)
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice
Yukari Kuramoto et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses
De Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
Mirjam Kool et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates
Abu-Baker M. Abdel-Aal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Glycopeptide dendrimers, Part III -: a review:: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases
Petr Niederhafner et al.
JOURNAL OF PEPTIDE SCIENCE (2008)
Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses
Bao-Zhong Wang et al.
JOURNAL OF VIROLOGY (2008)
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2
Tatsukata Kawagoe et al.
NATURE IMMUNOLOGY (2008)
Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides
Jennifer M. Dan et al.
PLOS ONE (2008)
The TLR3 signaling complex forms by cooperative receptor dimerization
Joshua N. Leonard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines
Qing Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cationic liposomal lipids: From gene carriers to cell signaling
Caroline Lonez et al.
PROGRESS IN LIPID RESEARCH (2008)
Synergistic effects of chemical insult and toll-like receptor ligands on dendritic cell activation
Rebecca J. Dearman et al.
TOXICOLOGY IN VITRO (2008)
Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads
Deanne L. V. Greenwood et al.
VACCINE (2008)
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
Brendon Y. Chua et al.
VACCINE (2008)
A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression
Ilan Vaknin et al.
BLOOD (2008)
Portable flanking sequences modulate CTL epitope processing
Sylvie Le Gall et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide
Mi Sun Jin et al.
CELL (2007)
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran
Ho Min Kim et al.
CELL (2007)
L-BLP25: A peptide vaccine strategy in non-small cell lung cancer
Randeep Sangha et al.
CLINICAL CANCER RESEARCH (2007)
TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines
Dean Johnston et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α
Tarun K. Ghosh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells
Selina Khan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation
Xinshou Ouyang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation
C. Olive et al.
VACCINE (2007)
MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists
Aranya Bagchi et al.
JOURNAL OF IMMUNOLOGY (2007)
Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups
Brendon Y. Chua et al.
VACCINE (2007)
Methods and protocols for prediction of immunogenic epitopes
Joo Chuan Tong et al.
BRIEFINGS IN BIOINFORMATICS (2007)
Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools
Jason A. Greenbaum et al.
JOURNAL OF MOLECULAR RECOGNITION (2007)
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus
Patricia L. Mottram et al.
MOLECULAR PHARMACEUTICS (2007)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L. Gavin et al.
SCIENCE (2006)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Sai T. Reddy et al.
TRENDS IN IMMUNOLOGY (2006)
A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine
Juan Dupont et al.
VACCINE (2006)
Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine
Qin-Hui Xu et al.
BIOCONJUGATE CHEMISTRY (2006)
Rapid and efficient identification of epitopes/mimotopes from random peptide libraries
Xiaoli Yu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy
Sjoerd H. van der Burg et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles
Sai T. Reddy et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant:: therapeutic activity against human cervical cancer in a rodent model
Zhengrong Cui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Saponin-adjuvanted particulate vaccines for clinical use
Caroline D. Skene et al.
METHODS (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Immunostimulation of dendritic cells by cationic liposomes
Dileep P. Vangasseri et al.
MOLECULAR MEMBRANE BIOLOGY (2006)
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein
Colleen Olive et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
Tobias Warger et al.
BLOOD (2006)
Targeting signal transduction as a strategy to treat inflammatory diseases
Luke A. J. O'Neill
NATURE REVIEWS DRUG DISCOVERY (2006)
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes
Karen Zaks et al.
JOURNAL OF IMMUNOLOGY (2006)
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus
Colleen Olive et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Toll-like receptor agonists infl uence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates
Ulrike Wille-Reece et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
TLR signaling
T Kawai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults
C Durier et al.
AIDS (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Prospects for exosomes in immunotherapy of cancer
G. Mignot et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Human dendritic cells following Aspergillus fumigatus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response
V Gafa et al.
INFECTION AND IMMUNITY (2006)
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
J Kazzaz et al.
JOURNAL OF CONTROLLED RELEASE (2006)
How Toll-like receptors signal: what we know and what we don't know
LAJ O'Neill
CURRENT OPINION IN IMMUNOLOGY (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
The 'co-delivery' approach to liposomal vaccines: Application to the development of influenza-A and hepatitis-B vaccine candidates
Peter Laing et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
Triggering TLR signaling in vaccination
D van Duin et al.
TRENDS IN IMMUNOLOGY (2006)
Artificial carriers: A strategy for constructing antigenic/immunogenic conjugates
Maria Sakarellos-Daitsiotis et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses
L Pelkmans
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
A Bafica et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice
A Luzardo-Alvarez et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Synergistic effect of Nod1 and Nod2 Agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells
H Tada et al.
INFECTION AND IMMUNITY (2005)
Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines
E Bergfors et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer
C Butts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system
I Rosenkrands et al.
INFECTION AND IMMUNITY (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
The evolution of vertebrate Toll-like receptors
JC Roach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Exosomal-like vesicles are present in human blood plasma
MP Caby et al.
INTERNATIONAL IMMUNOLOGY (2005)
Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses
U Wille-Reece et al.
JOURNAL OF IMMUNOLOGY (2005)
Negative regulation of Toll-like receptor-mediated immune responses
FY Liew et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines
A Heit et al.
JOURNAL OF IMMUNOLOGY (2005)
Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells
S Espuelas et al.
MOLECULAR IMMUNOLOGY (2005)
HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays
JD Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung et al.
NATURE MEDICINE (2005)
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88
U Hasan et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
CSW Chong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy
CL Finstad et al.
VACCINE (2004)
Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
F André et al.
JOURNAL OF IMMUNOLOGY (2004)
Exosomes as potent cell-free peptide-based vaccine.: II.: Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection
N Chaput et al.
JOURNAL OF IMMUNOLOGY (2004)
Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects
T Storni et al.
JOURNAL OF IMMUNOLOGY (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T gondii infection
F Aline et al.
INFECTION AND IMMUNITY (2004)
Current status and potential application of ISCOMs in veterinary medicine
B Morein et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
CL van Broekhoven et al.
CANCER RESEARCH (2004)
Liposome adjuvants prepare from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses
GD Sprott et al.
VACCINE (2004)
Mechanistic actions of the risks and adverse events associated with vaccine administration
EH Moylett et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Modulating vaccine responses with dendritic cells and Toll-like receptors
B Pulendran
IMMUNOLOGICAL REVIEWS (2004)
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
DC Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
C Foged et al.
VACCINE (2004)
Lipid raft-associated protein sorting in exosomes
A de Gassart et al.
BLOOD (2003)
Most lymphoid organ dendritic cell types are phenotypically and functionally immature
NS Wilson et al.
BLOOD (2003)
Dissecting the role of peptides in the immune response: Theory, practice and the application to vaccine design
AW Purcell et al.
JOURNAL OF PEPTIDE SCIENCE (2003)
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens
C Olive et al.
INFECTION AND IMMUNITY (2003)
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway
M Yamamoto et al.
NATURE IMMUNOLOGY (2003)
Biomimetic design in microparticulate vaccines
ME Keegan et al.
BIOMATERIALS (2003)
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines
WG Zeng et al.
JOURNAL OF IMMUNOLOGY (2002)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo
KD Newman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide
N Shinobu et al.
FEBS LETTERS (2002)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L Thiele et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Self-assembly of model collagen peptide amphiphiles
T Gore et al.
LANGMUIR (2001)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity
WG Zeng et al.
VACCINE (2001)
Surface-linked liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes
Y Nakano et al.
BIOCONJUGATE CHEMISTRY (2001)
Liposome-mediated DNA vaccination: the effect of vesicle composition
Y Perrie et al.
VACCINE (2001)
Type 1 type 2 immunity in infectious diseases
B Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice
MC De Oliveira et al.
LIFE SCIENCES (2000)
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity
B Ludewig et al.
VACCINE (2000)
分享论文
